Smoking History and Epidermal Growth Factor Receptor Expression as Predictors of Survival Benefit from Erlotinib for Patients with Non–Small-Cell Lung Cancer in the National Cancer Institute of Canada Clinical Trials Group Study BR.21

Autor: Clark, Gary M., Zborowski, Denni M., Santabárbara, Pedro, Ding, Keyue, Whitehead, Marlo, Seymour, Lesley, Shepherd, Frances A.
Zdroj: In Clinical Lung Cancer May 2006 7(6):389-394
Databáze: ScienceDirect